Federal AI Intelligence
Menu
Snapshot · OMB 2025 inventory · processed Oct 11, 2026
HHS · no agency ID · record R0824

Renamed: Extracting DMF Facilities from unstructured documents Previously: DMF (Drug Master File) Facilities

Department of Health and Human Services · HHS/FDA/CDER

Overview

Development stage
DeployedSource: c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.
High-impact designation
Not high-impactSource: c) Not high-impact
Impact justification
Not reported
Start date
2023-06 (month precision)Source: Jun-23
Withheld from public reporting
NoSource: a) No

Mission

Topic area
Health and Medical
Operational functions
Document processing and extraction Derived by keyword rules; see methodology

Problem the AI is intended to solve

FDA receives Drug Master File (DMF) submissions containing valuable information about manufacturing facilities, but this data exists in various document formats that require manual review to compile comprehensive facility information.

Expected benefits

Extracts facility references from Type II (Drug Substance) DMF manufacturing submissions (i.e., DMF123456 discloses that it uses Facility X for manufacturing and Facility Y for stability testing). These DMF submissions may include structured documents (3938 form) or unstructured documents (electronic Common Technical Document module 3), enabling more comprehensive oversight of the drug supply chain.

System outputs

Support information extraction from unstructured documents

Technology

AI classification
Natural language processingSource: Natural Language Processing: AI that processes, interprets, and shares information in human language.
System name(s)
CDEROne Analytics: FISMA-high environment
Custom-developed code
Yes
Public source code
Not reported

Sourcing

How it was built
Contract and in-houseSource: c) Developed with both contracting and in-house resources
Vendor (as reported)
Deloitte
Vendors (standardized)
Deloitte

A vendor is the supplier named by the agency. It does not identify the underlying model or AI technology.

Data and privacy

Involves PII
No
Privacy Impact Assessment
Not reported
Authorization to Operate
Yes
Demographic features
k) None of the above
Training and evaluation data
Applicant submissions
Federal Data Catalog
Not reported

Governance

0 of 8 minimum-practice questions answered. A blank answer means the agency reported nothing; it does not mean the practice is absent.

Pre-deployment testingNo answer reported
AI impact assessmentNo answer reported
Independent reviewNo answer reported
Ongoing monitoringNo answer reported
Operator trainingNo answer reported
Fail-safeNo answer reported
Appeal processNo answer reported
User and public consultationNo answer reported

Potential impacts and how they were identified

Not reported